PVCT Shariah Compliance
Screening Methodology: AAOIFI
LOCKED
Provectus Biopharmaceuticals Inc. Stock Analysis PVCT
United States Health Care Nano Cap Provectus Biopharmaceuticals, Inc. is a development stage biopharmaceutical company, which engages in the development of ethical pharmaceuticals for oncology and dermatology indications. The company is headquartered in Knoxville, Tennessee and currently employs 4 full-time employees. The company went IPO on 2000-04-07. The firm is engaged in developing immunotherapy medicines for different diseases that are based on a class of synthetic small-molecule immuno-catalysts called halogenated xanthenes (HXs). The Company’s lead molecule is named rose bengal sodium (RBS). The Company’s small molecule HX medical science platform comprises a range of different drug product candidates and preclinical pharmaceutical-grade RBS formulations using different concentrations and delivered by different routes of administration specific to each disease area and/or indication. The Company’s HX medical science platform includes clinical development programs in oncology, dermatology, and ophthalmology; in vivo proof-of-concept drug discovery programs in oncology, hematology, wound healing, and animal health, and in vitro drug discovery programs in infectious diseases and tissue regeneration and repair.
Read More PVCT Chart
Provectus Biopharmaceuticals Inc vs S&P 500 Comparative Returns
Analysis of PVCT stock performance compared to the broader market (S&P 500) across multiple timeframes.
YTD Performance
- Provectus Bioph... (PVC...) -29.14%
- S&P 500 -4.27%
Provectus Bioph... Underperformed S&P 500 by 24.87%
1Y Performance
- Provectus Bioph... (PVC...) -52.4%
- S&P 500 8.86%
Provectus Bioph... Underperformed S&P 500 by 61.26%
3Y Performance
- Provectus Bioph... (PVC...) 41.36%
- S&P 500 37.21%
Provectus Bioph... Outperformed S&P 500 by 4.15%
5Y Performance
- Provectus Bioph... (PVC...) 83.01%
- S&P 500 92.3%
Provectus Bioph... Underperformed S&P 500 by 9.29%
Key Statistics
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.09Volume
15.40KP/E Ratio (TTM)
-52 Week Range
Market Cap
41.02MAvg. Volume
130.70KDividend Yield
-Financial Metrics & Statements
- Per Share Data
- Ratios
- Statements
| Currency: USD | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
Revenue per Share (TTM) | 0 | 0 | 0 | 0 | - |
EBIT per Share (TTM) | -0.01 | -0.01 | -0.01 | -0.01 | - |
Earnings per Share (EPS) (TTM) | - | - | 0 | 0 | - |
EPS Forward | - | -0.01 | -0.01 | -0.01 | - |
FAQ's
Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.
Alternate Halal Stocks
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
